End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,100 KRW | +21.27% | +26.56% | +3.04% |
16/05 | Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/03 | Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 127B 91.65M 7.65B | Sales 2023 | 135B 98.01M 8.18B | Capitalization | 120B 86.8M 7.24B |
---|---|---|---|---|---|
Net income 2022 | 3.56B 2.58M 215M | Net income 2023 | -8.42B -6.09M -508M | EV / Sales 2022 | 1.02 x |
Net Debt 2022 | 23.04B 16.68M 1.39B | Net Debt 2023 | 20.03B 14.5M 1.21B | EV / Sales 2023 | 1.03 x |
P/E ratio 2022 |
29.9
x | P/E ratio 2023 |
-14.2
x | Employees | 259 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.37% |
1 day | +21.27% | ||
1 week | +26.56% | ||
Current month | +28.56% | ||
1 month | +22.49% | ||
3 months | +29.24% | ||
6 months | -3.02% | ||
Current year | +3.04% |
Managers | Title | Age | Since |
---|---|---|---|
Tae-Hoon Nam
CEO | Chief Executive Officer | 43 | 01/09/01 |
Young-Woo Nam
CEO | Chief Executive Officer | 82 | 01/05/01 |
Sung-Kyu Kim
COO | Chief Operating Officer | 60 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ga-Won Lee
BRD | Director/Board Member | 44 | 01/20/01 |
Young-Woo Nam
CEO | Chief Executive Officer | 82 | 01/05/01 |
Tae-Hoon Nam
CEO | Chief Executive Officer | 43 | 01/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 6,100 | +21.27% | 14,375,380 |
14/24/14 | 5,030 | -2.52% | 783,644 |
13/24/13 | 5,160 | +4.77% | 1,782,897 |
12/24/12 | 4,925 | +3.90% | 3,655,392 |
11/24/11 | 4,740 | -1.66% | 1,571,403 |
End-of-day quote Korea S.E., June 17, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+3.04% | 89.43M | |
+20.76% | 43.54B | |
+18.62% | 21.51B | |
+18.29% | 15.34B | |
+26.36% | 15.12B | |
+56.55% | 13.37B | |
-0.05% | 6.79B | |
-14.94% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.36B |
- Stock Market
- Equities
- A002720 Stock